Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anita Langerød

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Cold Spring Harbor Perspectives in Medicine|November 6, 2016
TP53 Mutations in Breast and Ovarian CancerLaxmi Silwal-Pandit, Anita Langerød, Anne-Lise Børresen-Dale
Cancer Letters|November 13, 2010
p53-Dependent repression of focal adhesion kinase in response to estradiol in breast cancer cell-linesSuresh Anaganti, Lynnette Fernández-Cuesta, Anita Langerød, et al.
Human Mutation|October 1, 2003
BUB1 infrequently mutated in human breast carcinomasAnita Langerød, Maria Strømberg, Koei Chin, et al.
The Open Virology Journal|May 15, 2009
Human papillomavirus DNA and e6/e7 mRNA status in relation to survival of patients treated for cervical squamous cell carcinomaRuth Holm, Irene Kraus, Hanne Skomedal, et al.
Breast Cancer Research and Treatment|August 12, 2003
Overexpression of cyclin A overrides the effect of p53 alterations in breast cancer patients with long follow-up timeIda R K Bukholm, Anne Husdal, Jahn M Nesland, et al.
Virchows Archiv : an International Journal of Pathology|December 18, 2012
AZGP1 and SPDEF mRNA expression differentiates breast carcinoma from ovarian serous carcinomaHelene Tuft Stavnes, Dag André Nymoen, Anita Langerød, et al.
Molecular Oncology|May 1, 2009
Full sequencing of TP53 identifies identical mutations within in situ and invasive components in breast cancer suggesting clonal evolutionWenjing Zhou, Aslaug A Muggerud, Phuong Vu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
Gene expression profiling of breast cancer in relation to estrogen receptor status and estrogen-metabolizing enzymes: clinical implicationsVessela N Kristensen, Therese Sørlie, Jurgen Geisler, et al.
Plos One|March 23, 2011
Combining gene signatures improves prediction of breast cancer survivalXi Zhao, Einar Andreas Rødland, Therese Sørlie, et al.
BMC Cancer|December 2, 2010
BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutationsHenne Holstege, Hugo M Horlings, Arno Velds, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Cold Spring Harbor Perspectives in Medicine|November 6, 2016
TP53 Mutations in Breast and Ovarian CancerLaxmi Silwal-Pandit, Anita Langerød, Anne-Lise Børresen-Dale
Cancer Letters|November 13, 2010
p53-Dependent repression of focal adhesion kinase in response to estradiol in breast cancer cell-linesSuresh Anaganti, Lynnette Fernández-Cuesta, Anita Langerød, et al.
Human Mutation|October 1, 2003
BUB1 infrequently mutated in human breast carcinomasAnita Langerød, Maria Strømberg, Koei Chin, et al.
The Open Virology Journal|May 15, 2009
Human papillomavirus DNA and e6/e7 mRNA status in relation to survival of patients treated for cervical squamous cell carcinomaRuth Holm, Irene Kraus, Hanne Skomedal, et al.
Breast Cancer Research and Treatment|August 12, 2003
Overexpression of cyclin A overrides the effect of p53 alterations in breast cancer patients with long follow-up timeIda R K Bukholm, Anne Husdal, Jahn M Nesland, et al.
Virchows Archiv : an International Journal of Pathology|December 18, 2012
AZGP1 and SPDEF mRNA expression differentiates breast carcinoma from ovarian serous carcinomaHelene Tuft Stavnes, Dag André Nymoen, Anita Langerød, et al.
Molecular Oncology|May 1, 2009
Full sequencing of TP53 identifies identical mutations within in situ and invasive components in breast cancer suggesting clonal evolutionWenjing Zhou, Aslaug A Muggerud, Phuong Vu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
Gene expression profiling of breast cancer in relation to estrogen receptor status and estrogen-metabolizing enzymes: clinical implicationsVessela N Kristensen, Therese Sørlie, Jurgen Geisler, et al.
Plos One|March 23, 2011
Combining gene signatures improves prediction of breast cancer survivalXi Zhao, Einar Andreas Rødland, Therese Sørlie, et al.
BMC Cancer|December 2, 2010
BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutationsHenne Holstege, Hugo M Horlings, Arno Velds, et al.
Pageof 5